Perrigo | PRGO - Net Income


Perrigo reported $-1.42B in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
AbbVie USD 1.82B 1.63B Dec/2025
Abbott USD 1.08B 699M Mar/2026
Bayer EUR -3.76B 2.79B Dec/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Coherus Biosciences USD -37.64M 2.11M Dec/2025
Corcept Therapeutics USD 24.29M 4.62M Dec/2025
Dr.Reddys Laboratories INR 12.1B 2.27B Dec/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
J&J USD 5.24B 119M Mar/2026
Merck USD 2.96B 2.82B Dec/2025
Nestle CHF 3.97B 1.1B Dec/2025
Pacira USD 1.64M 3.8M Dec/2025
Perrigo USD -1.42B 1.43B Dec/2025
Pfizer USD -1.65B 5.19B Dec/2025
Phibro Animal Health USD 27.46M 932K Dec/2025
Prestige Brands USD 46.7M 22.44M Dec/2025
Reckitt Benckiser GBP 284M 287M Dec/2024
Sanofi EUR 1.61B 2.42B Mar/2026
Supernus Pharmaceuticals USD -45.12M 67.62M Sep/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025
Zoetis USD 603M 118M Dec/2025